Skip to main content
Top
Published in: Infection 5/2014

01-10-2014 | Clinical and Epidemiological Study

Infective endocarditis in Rio de Janeiro, Brazil: a 5-year experience at two teaching hospitals

Authors: P. V. Damasco, J. N. Ramos, J. C. D. Correal, M. V. Potsch, V. V. Vieira, T. C. F. Camello, M. P. Pereira, V. D. Marques, K. R. N. Santos, E. A. Marques, M. B. Castier, R. Hirata Jr., A. L. Mattos-Guaraldi, C. Q. Fortes

Published in: Infection | Issue 5/2014

Login to get access

Abstract

Introduction

Despite the recent advances in diagnosis and treatment, mortality rates due to infective endocarditis (IE) remain high if not aggressively treated with antibiotics, whether or not associated with surgery. Data on the prevalence, epidemiology and etiology of IE from developing countries remain scarce. The aim of this observational, prospective cohort study was to report a 5-year experience of IE at two teaching hospitals in Rio de Janeiro, Brazil.

Material and methods

Demographical, anamnestic and microbiological characteristics of 71 IE patients were evaluated during the period of January 2009 to March 2013.

Results

The mean age of the IE patients was 49.8 ± 2.4 years, of which 41 (57.7 %) were males. The median time between the onset of symptoms and diagnosis of IE was 35.8 ± 4.8 days. A total of 31 (43.6 %) cases of community-acquired infective endocarditis (CAIE) and 40 (56.3 %) cases of healthcare-acquired infective endocarditis (HAIE) were observed. Staphylococcus aureus (30 %) was the predominant cause of IE. Streptococcus spp. (45.1 %) was the predominant cause of the CAIE while S. aureus (32.5 %) and Enterococcus spp. (27.2 %) were the main etiological agents of HAIE. For 64 (90.1 %) patients with native valve endocarditis, the mitral valve was the most commonly affected (48.3 %). The main source of IE in this cohort was intravascular catheter. The tricuspid valve and renal chronic insufficiency were more frequent in patients with HAIE than CAIE (p = 0.001). The risk factors associated with in-hospital mortality rate (46.4 %) in IE patients were: age over 45 (OR 3.4; 95 % CI 1.03–11.24; p = 0.04) and chronic renal insufficiency (OR 38.3; 95 % CI 3.2–449.4; p = 0.004).

Conclusions

At two main teaching hospitals in Brazil, Streptococcus spp. was the principal pathogen of CAIE while S. aureus and Enterococcus spp. were the most frequent causes of HAIE. IE remains a serious disease associated with high in-hospital mortality rate (46.6 %); especially, in individuals over 45 years of age and with renal failure. Data suggest that early surgery may improve the outcome of IE patients.
Literature
1.
go back to reference Sandre RM, Shafran SD. Infective endocarditis: review of 135 cases over 9 years. Clin Infect Dis. 1996;22:276–86.PubMedCrossRef Sandre RM, Shafran SD. Infective endocarditis: review of 135 cases over 9 years. Clin Infect Dis. 1996;22:276–86.PubMedCrossRef
2.
go back to reference Trabelsi I, Rekik S, Znazen A, Maaloul I, Abid D, Maalej A, Kharrat I, Jemaa MB, Hammemi A, Kammoun S. Native valve infective endocarditis in a tertiary care center in a developing country (Tunisia). Am J Cardiol. 2008;102:1247–51.PubMedCrossRef Trabelsi I, Rekik S, Znazen A, Maaloul I, Abid D, Maalej A, Kharrat I, Jemaa MB, Hammemi A, Kammoun S. Native valve infective endocarditis in a tertiary care center in a developing country (Tunisia). Am J Cardiol. 2008;102:1247–51.PubMedCrossRef
3.
go back to reference Nunes MC, Gelape CL, Ferrari TC. Profile of infective endocarditis at a tertiary care center in Brazil during a seven-year period: prognostic factors an in-hospital outcome. Int J Infect Dis. 2010;14:e394–8.PubMedCrossRef Nunes MC, Gelape CL, Ferrari TC. Profile of infective endocarditis at a tertiary care center in Brazil during a seven-year period: prognostic factors an in-hospital outcome. Int J Infect Dis. 2010;14:e394–8.PubMedCrossRef
4.
go back to reference Wu K, Lee SSJ, Tsai HC, Wann SR, Chen JK, Sy CL, Wang YH, Tseng YT, Chen YS. Non-nosocomial healthcare-associated infective endocarditis in Taiwan: an under recognized disease with poor outcome. BMC Infections. 2011;11:211–21. Wu K, Lee SSJ, Tsai HC, Wann SR, Chen JK, Sy CL, Wang YH, Tseng YT, Chen YS. Non-nosocomial healthcare-associated infective endocarditis in Taiwan: an under recognized disease with poor outcome. BMC Infections. 2011;11:211–21.
5.
go back to reference Hirata R Jr, Pereira GA, Filardy AA, Gomes DL, Damasco PV, Rosa AC, Nagao PE, Pimenta FP, Mattos-Guaraldi AL. Potential pathogenic role of aggregative-adhering Corynebacterium diphtheriae of different clonal groups in endocarditis. Braz JMed Biol Res. 2008;41:986–91.CrossRef Hirata R Jr, Pereira GA, Filardy AA, Gomes DL, Damasco PV, Rosa AC, Nagao PE, Pimenta FP, Mattos-Guaraldi AL. Potential pathogenic role of aggregative-adhering Corynebacterium diphtheriae of different clonal groups in endocarditis. Braz JMed Biol Res. 2008;41:986–91.CrossRef
6.
go back to reference Begezsan II, Dorobat CM. Diagnostic approaches in infective endocarditis. Rev Med Chir Soc Med Nat Iasi. 2012;116:108–13.PubMed Begezsan II, Dorobat CM. Diagnostic approaches in infective endocarditis. Rev Med Chir Soc Med Nat Iasi. 2012;116:108–13.PubMed
7.
go back to reference Thuny F, Grisoli D, Collart F, Habib G, Raoult D. Management of infective endocarditis: challenges and perspectives. Lancet. 2012;379:965–75.PubMedCrossRef Thuny F, Grisoli D, Collart F, Habib G, Raoult D. Management of infective endocarditis: challenges and perspectives. Lancet. 2012;379:965–75.PubMedCrossRef
9.
go back to reference Sousa C, Botelho C, Rodrigues D, Azeredo J, Oliveira R. Infective endocarditis in intravenous drug abusers: an update. Eur J ClinMicrobiol Infect Dis. 2012;31:2905–10.CrossRef Sousa C, Botelho C, Rodrigues D, Azeredo J, Oliveira R. Infective endocarditis in intravenous drug abusers: an update. Eur J ClinMicrobiol Infect Dis. 2012;31:2905–10.CrossRef
10.
go back to reference Damasco PV, Cavalcante FS, Chamon RC, Ferreira DC, Rioja SS, Potsch MV, Pastura MP, Marques VD, Castier MB, Marques EA, Santos KR. The first case report of non-nosocomial healthcare-associated infective endocarditis due to methicillin- resistant Staphylococcus aureus USA400 in Rio de Janeiro Brazil. Infection. 2013;41:851–4.PubMedCrossRef Damasco PV, Cavalcante FS, Chamon RC, Ferreira DC, Rioja SS, Potsch MV, Pastura MP, Marques VD, Castier MB, Marques EA, Santos KR. The first case report of non-nosocomial healthcare-associated infective endocarditis due to methicillin- resistant Staphylococcus aureus USA400 in Rio de Janeiro Brazil. Infection. 2013;41:851–4.PubMedCrossRef
11.
go back to reference Tariq M, Alam M, Munir G, Khan MA, Smego RA Jr. Infective endocarditis: a five experience at tertiary care hospital in Pakistan. Int J Infect Dis. 2004;8:163–70.PubMedCrossRef Tariq M, Alam M, Munir G, Khan MA, Smego RA Jr. Infective endocarditis: a five experience at tertiary care hospital in Pakistan. Int J Infect Dis. 2004;8:163–70.PubMedCrossRef
12.
go back to reference Ruiz BM. Castillo Rivera AM, Navarro RC. Infectious endocarditis in intensive care medicine. Med Intensiva. 2012;36:457–9.CrossRef Ruiz BM. Castillo Rivera AM, Navarro RC. Infectious endocarditis in intensive care medicine. Med Intensiva. 2012;36:457–9.CrossRef
13.
go back to reference Lomas JM, Martinez-Marcos FJ, Placa A, Ivanova R, Gálvez J, Ruiz J, Reguera JM, Noureddine M, de la Torre J, de Alcarcón A. Healthcare-associated infective endocarditis: an undesirable effect of healthcare universalization. Clin Microbiol Infect. 2010;16:1683–90.PubMedCrossRef Lomas JM, Martinez-Marcos FJ, Placa A, Ivanova R, Gálvez J, Ruiz J, Reguera JM, Noureddine M, de la Torre J, de Alcarcón A. Healthcare-associated infective endocarditis: an undesirable effect of healthcare universalization. Clin Microbiol Infect. 2010;16:1683–90.PubMedCrossRef
14.
go back to reference Carroll KC, Weinstein MP. Manual and automated systems for detection and identification of microorganisms. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, editors. Manual of clinical microbiology. 9th ed. Washington, DC: ASM Press; 2007. p. 192–217. Carroll KC, Weinstein MP. Manual and automated systems for detection and identification of microorganisms. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, editors. Manual of clinical microbiology. 9th ed. Washington, DC: ASM Press; 2007. p. 192–217.
15.
go back to reference Mory F, Alauzet C, Matuszeswski C, Riegel P, Lozniewski A. Evaluation of the new vitek 2 anc card for identification of medically relevant anaerobic bacteria. J Clin Microbiol. 2009;47:1923–6.PubMedCrossRefPubMedCentral Mory F, Alauzet C, Matuszeswski C, Riegel P, Lozniewski A. Evaluation of the new vitek 2 anc card for identification of medically relevant anaerobic bacteria. J Clin Microbiol. 2009;47:1923–6.PubMedCrossRefPubMedCentral
16.
go back to reference Clinical and laboratory standards institute. performance for standards for antimicrobial susceptibility testing; twenty-third informational supplement. CLSI document M100-S-23. 2013. Clinical and laboratory standards institute. performance for standards for antimicrobial susceptibility testing; twenty-third informational supplement. CLSI document M100-S-23. 2013.
17.
go back to reference Fernández-Hidalgo N, Almirante B, Tornos P, Pigrau C, Sambola A, Igual A, Pahissa A. Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clin Infect Dis. 2008;47:1287–97.PubMedCrossRef Fernández-Hidalgo N, Almirante B, Tornos P, Pigrau C, Sambola A, Igual A, Pahissa A. Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clin Infect Dis. 2008;47:1287–97.PubMedCrossRef
18.
go back to reference Sucutu M, Davutoglu V, Ozer O, Aksoy M. Epidemiological, clinical and microbiological profile of infective endocarditis in a tertiary hospital in the South-East Anatolia region. Arch Turk Soc Cardiol. 2010;38:107–11. Sucutu M, Davutoglu V, Ozer O, Aksoy M. Epidemiological, clinical and microbiological profile of infective endocarditis in a tertiary hospital in the South-East Anatolia region. Arch Turk Soc Cardiol. 2010;38:107–11.
19.
go back to reference Ferreiros E, Nacinovich F, Casabé JH, Modenesi JC, Swieszkowski S, Corte C, Hernan CA, Kazelian L, Varini S. Epidemiologic, clinical and microbiologic profile of infective endocarditis in Argentina: a national survey. Am Heart J. 2006;151:545–52.PubMedCrossRef Ferreiros E, Nacinovich F, Casabé JH, Modenesi JC, Swieszkowski S, Corte C, Hernan CA, Kazelian L, Varini S. Epidemiologic, clinical and microbiologic profile of infective endocarditis in Argentina: a national survey. Am Heart J. 2006;151:545–52.PubMedCrossRef
20.
go back to reference Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS, ICE Investigators. Staphylococcus aureus endocarditis a consequence of medical progress. JAMA. 2005;293:3022–61.CrossRef Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS, ICE Investigators. Staphylococcus aureus endocarditis a consequence of medical progress. JAMA. 2005;293:3022–61.CrossRef
21.
go back to reference Garg N, Kandpal B, Garg N, Tewari S, Kapoor A, Goel P, Sinha N. Characteristics of infective endocarditis in a developing country-clinical profile and outcome in 192 Indian patients, 1992–2001. Int J Cardiol. 2005;98:253–60.PubMedCrossRef Garg N, Kandpal B, Garg N, Tewari S, Kapoor A, Goel P, Sinha N. Characteristics of infective endocarditis in a developing country-clinical profile and outcome in 192 Indian patients, 1992–2001. Int J Cardiol. 2005;98:253–60.PubMedCrossRef
22.
go back to reference Yen HS, Murdoch DR. Global trends in infective endocarditis epidemiology. Curr Infect Dis Rep. 2012;14:367–72.CrossRef Yen HS, Murdoch DR. Global trends in infective endocarditis epidemiology. Curr Infect Dis Rep. 2012;14:367–72.CrossRef
23.
24.
go back to reference Sy RW, kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary population based profile of 1536 patients in Australia. Eur Heart J. 2010;31:1890–7.PubMedCrossRef Sy RW, kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary population based profile of 1536 patients in Australia. Eur Heart J. 2010;31:1890–7.PubMedCrossRef
25.
go back to reference Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte, Chirouze C, Lung B, Strady C, Revest M, Vandenesch F, Bouvet A, Delahaye F, Alfa F, Duval X, Hoen. Preeminence of Staphylococcus aureus in infective endocarditis: a 1 year population based survey. Clin Infect Dis. 2012;54:1230–9.PubMedCrossRef Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte, Chirouze C, Lung B, Strady C, Revest M, Vandenesch F, Bouvet A, Delahaye F, Alfa F, Duval X, Hoen. Preeminence of Staphylococcus aureus in infective endocarditis: a 1 year population based survey. Clin Infect Dis. 2012;54:1230–9.PubMedCrossRef
26.
go back to reference Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis prospective cohort study. Arch Intern Med. 2009;169:463–73.PubMedCrossRefPubMedCentral Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis prospective cohort study. Arch Intern Med. 2009;169:463–73.PubMedCrossRefPubMedCentral
27.
go back to reference Geiβdörfer W, Moos V, Moter A, Loddenkemper C, Jansen A, Tandler R, Morguet AJ, Fenollar F, Raoult D, Bogdan C, Schneider T. High frequency of Tropheryma whipplei in culture negative endocarditis. J Clin Microbiol. 2012;50:216–22.CrossRef Geiβdörfer W, Moos V, Moter A, Loddenkemper C, Jansen A, Tandler R, Morguet AJ, Fenollar F, Raoult D, Bogdan C, Schneider T. High frequency of Tropheryma whipplei in culture negative endocarditis. J Clin Microbiol. 2012;50:216–22.CrossRef
28.
go back to reference Yiu KH, Siu CW, Lee KL, Fong YT, Chan HW, Lee SW, Lau CP, Tse HF. Emerging trends of community acquired infective endocarditis. Int J Cardiol. 2007;121:119–22.PubMedCrossRef Yiu KH, Siu CW, Lee KL, Fong YT, Chan HW, Lee SW, Lau CP, Tse HF. Emerging trends of community acquired infective endocarditis. Int J Cardiol. 2007;121:119–22.PubMedCrossRef
29.
go back to reference Ramos JN, Santos LS, Vidal LMR, Pereira PMA, Salgado AA, Fortes CQ, Vieira VV, Mattos-Guaraldi AL, Hirata Jr R, Damasco PV. A case report and literature overview: Abiotrophia defectiva aortic valve endocarditis in developing countries. Infection 2014; [Epub ahead of print]. Ramos JN, Santos LS, Vidal LMR, Pereira PMA, Salgado AA, Fortes CQ, Vieira VV, Mattos-Guaraldi AL, Hirata Jr R, Damasco PV. A case report and literature overview: Abiotrophia defectiva aortic valve endocarditis in developing countries. Infection 2014; [Epub ahead of print].
Metadata
Title
Infective endocarditis in Rio de Janeiro, Brazil: a 5-year experience at two teaching hospitals
Authors
P. V. Damasco
J. N. Ramos
J. C. D. Correal
M. V. Potsch
V. V. Vieira
T. C. F. Camello
M. P. Pereira
V. D. Marques
K. R. N. Santos
E. A. Marques
M. B. Castier
R. Hirata Jr.
A. L. Mattos-Guaraldi
C. Q. Fortes
Publication date
01-10-2014
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 5/2014
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-014-0640-2

Other articles of this Issue 5/2014

Infection 5/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine